In the mouse model, [fam-] trastuzumab deruxtecan induced the expression of dendritic cell activation makers, upregulation of MHC class I in tumor cells, activation of CD8+ T cells in tumors, and formation of immune memory. The gene discussed is CD8A; the disease is neoplasm.